BIOMAT Database Logo BIOMAT Database Logo

[Serum ferritin during hemodialysis. II: Outline for iron therapy]. 1982

J E Marco Franco, and A Alarcón Zurita, and A Morey Molina, and C Pizá Buñola, and J Bestard Palmer, and S Mairata Bosch, and A Galmés Llodra, and M Dalmau Diana

UI MeSH Term Description Entries
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D007501 Iron A metallic element with atomic symbol Fe, atomic number 26, and atomic weight 55.85. It is an essential constituent of HEMOGLOBINS; CYTOCHROMES; and IRON-BINDING PROTEINS. It plays a role in cellular redox reactions and in the transport of OXYGEN. Iron-56,Iron 56
D005293 Ferritins Iron-containing proteins that are widely distributed in animals, plants, and microorganisms. Their major function is to store IRON in a nontoxic bioavailable form. Each ferritin molecule consists of ferric iron in a hollow protein shell (APOFERRITINS) made of 24 subunits of various sequences depending on the species and tissue types. Basic Isoferritin,Ferritin,Isoferritin,Isoferritin, Basic
D006435 Renal Dialysis Therapy for the insufficient cleansing of the BLOOD by the kidneys based on dialysis and including hemodialysis, PERITONEAL DIALYSIS, and HEMODIAFILTRATION. Dialysis, Extracorporeal,Dialysis, Renal,Extracorporeal Dialysis,Hemodialysis,Dialyses, Extracorporeal,Dialyses, Renal,Extracorporeal Dialyses,Hemodialyses,Renal Dialyses
D006486 Hemosiderosis Conditions in which there is a generalized increase in the iron stores of body tissues, particularly of liver and the MONONUCLEAR PHAGOCYTE SYSTEM, without demonstrable tissue damage. The name refers to the presence of stainable iron in the tissue in the form of hemosiderin. Hemosideroses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D000747 Anemia, Hypochromic Anemia characterized by a decrease in the ratio of the weight of hemoglobin to the volume of the erythrocyte, i.e., the mean corpuscular hemoglobin concentration is less than normal. The individual cells contain less hemoglobin than they could have under optimal conditions. Hypochromic anemia may be caused by iron deficiency from a low iron intake, diminished iron absorption, or excessive iron loss. It can also be caused by infections or other diseases, therapeutic drugs, lead poisoning, and other conditions. (Stedman, 25th ed; from Miale, Laboratory Medicine: Hematology, 6th ed, p393) Chlorosis,Anemias, Hypochromic,Chloroses,Hypochromic Anemia,Hypochromic Anemias

Related Publications

J E Marco Franco, and A Alarcón Zurita, and A Morey Molina, and C Pizá Buñola, and J Bestard Palmer, and S Mairata Bosch, and A Galmés Llodra, and M Dalmau Diana
[Serum ferritin and iron therapy in patients treated with periodic hemodialysis].
December 1982, Quaderni Sclavo di diagnostica clinica e di laboratorio,
J E Marco Franco, and A Alarcón Zurita, and A Morey Molina, and C Pizá Buñola, and J Bestard Palmer, and S Mairata Bosch, and A Galmés Llodra, and M Dalmau Diana
Serum iron, ferritin, and vitamin B12 during prolonged omeprazole therapy.
June 1992, Journal of clinical gastroenterology,
J E Marco Franco, and A Alarcón Zurita, and A Morey Molina, and C Pizá Buñola, and J Bestard Palmer, and S Mairata Bosch, and A Galmés Llodra, and M Dalmau Diana
Serum iron, serum ferritin and tissue ferritin during development in ducks.
January 1987, Comparative biochemistry and physiology. A, Comparative physiology,
J E Marco Franco, and A Alarcón Zurita, and A Morey Molina, and C Pizá Buñola, and J Bestard Palmer, and S Mairata Bosch, and A Galmés Llodra, and M Dalmau Diana
Optimal Serum Ferritin Levels for Iron Deficiency Anemia during Oral Iron Therapy (OIT) in Japanese Hemodialysis Patients with Minor Inflammation and Benefit of Intravenous Iron Therapy for OIT-Nonresponders.
March 2018, Nutrients,
J E Marco Franco, and A Alarcón Zurita, and A Morey Molina, and C Pizá Buñola, and J Bestard Palmer, and S Mairata Bosch, and A Galmés Llodra, and M Dalmau Diana
Serum ferritin as a guide for iron stores in chronic hemodialysis patients.
October 1984, Kidney international,
J E Marco Franco, and A Alarcón Zurita, and A Morey Molina, and C Pizá Buñola, and J Bestard Palmer, and S Mairata Bosch, and A Galmés Llodra, and M Dalmau Diana
Serum ferritin level. Determinant of iron requirement in hemodialysis patients.
August 1977, JAMA,
J E Marco Franco, and A Alarcón Zurita, and A Morey Molina, and C Pizá Buñola, and J Bestard Palmer, and S Mairata Bosch, and A Galmés Llodra, and M Dalmau Diana
Serum ferritin and iron deficiency in patients on chronic hemodialysis.
January 1976, Transactions - American Society for Artificial Internal Organs,
J E Marco Franco, and A Alarcón Zurita, and A Morey Molina, and C Pizá Buñola, and J Bestard Palmer, and S Mairata Bosch, and A Galmés Llodra, and M Dalmau Diana
[Iron requirements of hemodialysis patients. Serum ferritin as an indicator].
April 1986, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke,
J E Marco Franco, and A Alarcón Zurita, and A Morey Molina, and C Pizá Buñola, and J Bestard Palmer, and S Mairata Bosch, and A Galmés Llodra, and M Dalmau Diana
Serum ferritin and iron stores during pregnancy.
February 1978, Clinica chimica acta; international journal of clinical chemistry,
J E Marco Franco, and A Alarcón Zurita, and A Morey Molina, and C Pizá Buñola, and J Bestard Palmer, and S Mairata Bosch, and A Galmés Llodra, and M Dalmau Diana
Serum ferritin and bone marrow iron in patient on maintenance hemodialysis.
August 1981, Taiwan yi xue hui za zhi. Journal of the Formosan Medical Association,
Copied contents to your clipboard!